These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8679535

  • 21. Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10.
    Shen L, Shah AM, Dahlbäck B, Nelsestuen GL.
    Biochemistry; 1997 Dec 23; 36(51):16025-31. PubMed ID: 9440875
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P, García de Frutos P, Nicolaes GA, Dahlbäck B.
    Thromb Haemost; 2000 Aug 23; 84(2):271-7. PubMed ID: 10959700
    [Abstract] [Full Text] [Related]

  • 24. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K, Siekmann J, Turecek PL, Schwarz HP, Marder VJ.
    Thromb Haemost; 1999 Dec 23; 82(6):1673-9. PubMed ID: 10613654
    [Abstract] [Full Text] [Related]

  • 25. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM, Kalafatis M, Tracy PB.
    Biochemistry; 1998 Aug 25; 37(34):11896-906. PubMed ID: 9718313
    [Abstract] [Full Text] [Related]

  • 26. The functions of the first epidermal growth factor homology region of human protein C as revealed by a charge-to-alanine scanning mutagenesis investigation.
    Cheng CH, Geng JP, Castellino FJ.
    Biol Chem; 1997 Dec 25; 378(12):1491-500. PubMed ID: 9461348
    [Abstract] [Full Text] [Related]

  • 27. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.
    Christiansen WT, Castellino FJ.
    Biochemistry; 1994 May 17; 33(19):5901-11. PubMed ID: 8180219
    [Abstract] [Full Text] [Related]

  • 28. Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised.
    Giri TK, García de Frutos P, Dahlbäck B.
    Thromb Haemost; 2000 Sep 17; 84(3):413-9. PubMed ID: 11019964
    [Abstract] [Full Text] [Related]

  • 29. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L, He X, Dahlbäck B.
    Thromb Haemost; 1997 Sep 17; 78(3):1030-6. PubMed ID: 9308749
    [Abstract] [Full Text] [Related]

  • 30. Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.
    Shen L, Shah AM, Dahlbäck B, Nelsestuen GL.
    J Biol Chem; 1998 Nov 20; 273(47):31086-91. PubMed ID: 9813008
    [Abstract] [Full Text] [Related]

  • 31. Recombinant rat protein C: comparative studies of structure, function and synthesis with plasma protein C.
    Ono M, Fujiwara H, Okafuji T, Enjoh T, Nawa K.
    Thromb Haemost; 1994 Jan 20; 71(1):54-61. PubMed ID: 8165647
    [Abstract] [Full Text] [Related]

  • 32. Ionic properties of membrane association by vitamin K-dependent proteins: the case for univalency.
    McDonald JF, Evans TC, Emeagwali DB, Hariharan M, Allewell NM, Pusey ML, Shah AM, Nelsestuen GL.
    Biochemistry; 1997 Dec 16; 36(50):15589-98. PubMed ID: 9398287
    [Abstract] [Full Text] [Related]

  • 33. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA, Thomassen MC, van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J.
    Thromb Haemost; 1996 Sep 16; 76(3):404-10. PubMed ID: 8883278
    [Abstract] [Full Text] [Related]

  • 34. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE, Rao NM, Hui SW, Cornell RB.
    Biochemistry; 1998 Jun 30; 37(26):9509-19. PubMed ID: 9649334
    [Abstract] [Full Text] [Related]

  • 35. Cardiolipin enhances protein C pathway anticoagulant activity.
    Fernández JA, Kojima K, Petäjä J, Hackeng TM, Griffin JH.
    Blood Cells Mol Dis; 2000 Apr 30; 26(2):115-23. PubMed ID: 10753602
    [Abstract] [Full Text] [Related]

  • 36. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ, Morse C, Murden SL, Brady SK, O'Donnell JS, Mumford AD.
    Br J Haematol; 2009 Mar 30; 144(6):946-53. PubMed ID: 19133979
    [Abstract] [Full Text] [Related]

  • 37. Membrane binding and anticoagulant properties of protein S natural variants.
    Baroni M, Pavani G, Marescotti D, Kaabache T, Borgel D, Gandrille S, Marchetti G, Legnani C, D'Angelo A, Pinotti M, Bernardi F.
    Thromb Res; 2010 Feb 30; 125(2):e33-9. PubMed ID: 19878975
    [Abstract] [Full Text] [Related]

  • 38. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.
    Berg DT, Gerlitz B, Shang J, Smith T, Santa P, Richardson MA, Kurz KD, Grinnell BW, Mace K, Jones BE.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4423-8. PubMed ID: 12671072
    [Abstract] [Full Text] [Related]

  • 39. An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG-->GGG). Deteriorated calcium-dependent conformation of the gamma-carboxyglutamic acid domain relevant to a thrombotic tendency.
    Mimuro J, Muramatsu S, Kaneko M, Yoshitake S, Iijima K, Nakamura K, Sakata Y, Matsuda M.
    Int J Hematol; 1993 Jan 15; 57(1):9-14. PubMed ID: 8477066
    [Abstract] [Full Text] [Related]

  • 40. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD, Safa O, Regan L, Mather T, Stearns-Kurosawa DJ, Kurosawa S, Rezaie AR, Esmon NL, Esmon CT.
    J Biol Chem; 1998 Apr 10; 273(15):9031-40. PubMed ID: 9535891
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.